SPONSOR
Shanghai HyaMab Biotech Co.,Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Locally Advanced/Metastatic Solid Tumors
Shanghai HyaMab Biotech Co.,Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Locally Advanced/Metastatic Solid Tumors.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai HyaMab Biotech Co.,Ltd.
How many clinical trials has Shanghai HyaMab Biotech Co.,Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Shanghai HyaMab Biotech Co.,Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Locally Advanced/Metastatic Solid Tumors. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai HyaMab Biotech Co.,Ltd. research focus on?
Shanghai HyaMab Biotech Co.,Ltd. clinical trials span Locally Advanced/Metastatic Solid Tumors. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai HyaMab Biotech Co.,Ltd. clinical trial?
To participate in a Shanghai HyaMab Biotech Co.,Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai HyaMab Biotech Co.,Ltd. trials with current recruitment status updated daily.
Clinical Trials by Shanghai HyaMab Biotech Co.,Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology